Valuation: PharmaEssentia Corporation

Market Cap 481B 14.75B 13.17B 12.17B 11.03B 20.63B 1,400B 20.97B 146B 57.97B 734B 55.35B 54.17B 2,313B P/E 2026 *
44x
P/E 2027 * 27.2x
Enterprise Value 458B 14.04B 12.54B 11.58B 10.5B 19.64B 1,333B 19.96B 139B 55.19B 698B 52.7B 51.58B 2,202B EV / Sales 2026 *
16.9x
EV / Sales 2027 * 10.8x
Free-Float
79.23%
Yield 2026 *
0.34%
Yield 2027 * 0.2%
1 day-1.28%
1 week-6.83%
Current month-4.53%
1 month-1.28%
3 months+0.87%
6 months+104.57%
Current year+173.78%
1 week 1,155
Extreme 1155
1,250
1 month 1,140
Extreme 1140
1,300
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 73.19
Extreme 73.192531
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 31/12/2016
Director of Finance/CFO - 13/10/2015
President - 24/06/2015
Director TitleAgeSince
Director/Board Member 73 30/04/2024
Director/Board Member - 04/08/2021
Director/Board Member - 26/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.28%-6.83%+155.82%+357.68% 14.75B
+2.41%+0.29%+42.02%+71.57% 64.69B
-0.15%+7.50%+11.01%+73.48% 54.78B
+0.57%+4.60%+10.07%+92.86% 53.49B
+0.37%+4.67%+27.03%+52.07% 45.98B
-1.21%+2.32%+21.80%+123.81% 42.94B
-0.37%+5.07%+249.91%+918.74% 40.08B
+0.05%+0.21%+18.26%+58.53% 33.52B
-0.38%+5.68%+36.43%+27.54% 23.67B
+1.19%-4.98%+29.01%-0.65% 23.97B
Average +0.12%+1.49%+60.14%+177.56% 39.79B
Weighted average by Cap. +0.33%+2.38%+51.58%+165.96%

Financials

2026 *2027 *
Net sales 27.07B 831M 742M 685M 621M 1.16B 78.84B 1.18B 8.24B 3.26B 41.31B 3.12B 3.05B 130B 41.5B 1.27B 1.14B 1.05B 952M 1.78B 121B 1.81B 12.64B 5B 63.33B 4.78B 4.68B 200B
Net income 10.52B 323M 288M 266M 241M 452M 30.65B 459M 3.2B 1.27B 16.06B 1.21B 1.19B 50.62B 17.96B 551M 492M 455M 412M 771M 52.31B 784M 5.47B 2.17B 27.41B 2.07B 2.02B 86.41B
Net Debt -23.05B -707M -631M -583M -529M -989M -67.12B -1.01B -7.02B -2.78B -35.17B -2.65B -2.6B -111B -34.24B -1.05B -938M -867M -785M -1.47B -99.72B -1.49B -10.43B -4.13B -52.25B -3.94B -3.86B -165B
Projected Income Statement - Annual - PharmaEssentia Corporation
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
22/10/26 NT$1,160.00 -1.28% 1,195,618
21/10/26 NT$1,175.00 +1.73% 1,496,190
20/10/26 NT$1,155.00 -1.70% 1,374,418
19/10/26 NT$1,175.00 -5.62% 2,610,708
16/10/26 NT$1,245.00 +3.32% 3,479,314
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - PharmaEssentia Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,160.00TWD
Average target price
1,437.27TWD
Spread / Average Target
+23.90%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PharmaEssentia Corporation
  1. Stock Market
  2. Stocks
  3. 6446 Stock